Literature DB >> 12478501

Antibiotics-why so many and when should we use them?

Dennis F Bandyk1.   

Abstract

Antibiotic prophylaxis in vascular surgery has been proven beneficial to reduce surgical site infections after reconstruction of the aorta, procedures on the leg that involve a groin incision, any procedure that implants a vascular prosthesis or endoluminal stent, and lower extremity amputation for ischemia. Bactericidal antibiotics administered before induction-cefazolin or cefuroxime for 1 to 2 days alone or in combination with vancomycin if a hospital wound surveillance program indicates a high incidence of methicillin-resistant Staphylococcus aureus infection-is recommended. If a patient is felt to be at increased risk for infection and require prosthetic grafting, the use of a rifampin-soaked (1 mg/mL) gelatin- or collagen-impregnated graft may decrease the incidence of wound and graft infection. Antibiotic treatment of established vascular graft infections should begin with broad-spectrum coverage for expected pathogens (S aureus, Staphylococcus epidermidis, Gram-negative bacteria) followed by culture-specific therapy based on antibiotic susceptibility testing. Specific antibiotic usage involves a decision regarding efficacy to expected or isolated pathogens versus its potential side effects and the drug costs. New applications for antibiotics in vascular surgery include the use of specific tetracyclines (doxycycline, azithromycin) as an inhibitor of matrix metalloproteinases to retard aortic aneurysm growth or for their antiinflammatory properties to retard atherogenesis related to Chylamydia pneumoniae. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12478501     DOI: 10.1053/svas.2002.36262

Source DB:  PubMed          Journal:  Semin Vasc Surg        ISSN: 0895-7967            Impact factor:   1.000


  4 in total

Review 1.  Mesh biocompatibility: effects of cellular inflammation and tissue remodelling.

Authors:  Karsten Junge; Marcel Binnebösel; Klaus T von Trotha; Raphael Rosch; Uwe Klinge; Ulf P Neumann; Petra Lynen Jansen
Journal:  Langenbecks Arch Surg       Date:  2011-04-01       Impact factor: 3.445

2.  Successful treatment of an infected thoracic endovascular stent graft.

Authors:  Taijiro Sueda; Shinya Takahashi; Keijiro Katayama; Katsuhiko Imai
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-07-04

Review 3.  How To Diagnose and Manage Infected Endografts after Endovascular Aneurysm Repair.

Authors:  Carlo Setacci; Emiliano Chisci; Francesco Setacci; Leonardo Ercolini; Gianmarco de Donato; Nicola Troisi; Giuseppe Galzerano; Stefano Michelagnoli
Journal:  Aorta (Stamford)       Date:  2014-12-01

4.  Systemic thioridazine in combination with dicloxacillin against early aortic graft infections caused by Staphylococcus aureus in a porcine model: In vivo results do not reproduce the in vitro synergistic activity.

Authors:  Michael Stenger; Carsten Behr-Rasmussen; Kasper Klein; Rasmus B Grønnemose; Thomas Emil Andersen; Janne K Klitgaard; Hans Jørn Kolmos; Jes S Lindholt
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.